Clinical Trial Update: Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of intraperitoneal catumaxomab followed by chemotherapy shows feasibility and signs of clinical activity in patients with recurrent epithelial o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Removab (catumaxomab)

Snippet

Sponsor: JSehouli | Conditions: Recurrent Epithelial Ovarian Cancer | Phase 2 | Status: COMPLETED